Skip to main content

Table 5 Univariate and multivariate analyses of the prognostic factors for disease-free survival

From: Prognostic value of tumor deposits and positive lymph nodes in colorectal cancer surgery: improved staging for long-term prognosis

Variables

Univariate analysis

Multivariate analysis

HR (95% CI)

P

HR (95% CI)

P

Tumor deposits

    

 No

 Ref.

 

 Ref.

 

 Yes

2.522 (2.016–3.156)

< 0.001

1.096 (0.839–1.433)

0.500

TD + PLNs

    

 0(N0)

 Ref.

 

 Ref.

 

 1–2(reN1)

1.994 (1.511–2.631)

< 0.001

1.176 (0.757–1.828)

0.470

 3+(reN2)

3.309 (2.625–4.171)

< 0.001

1.637 (1.063–2.521)

0.025

Age (years)

    

 <65

 Ref.

 

 Ref.

 

 ≥ 65

1.525 (1.241–1.875)

< 0.001

1.548 (1.237–1.936)

< 0.001

BMI

    

 <25

 Ref.

   

 ≥ 25

0.985 (0.764–1.27)

0.905

  

Tumor size (cm)

    

 ≤ 2.70

 Ref.

 

 Ref.

 

 >2.70

1.49 (1.112–1.997)

0.008

1.113 (0.817–1.515)

0.498

Obstruction before surgery

    

 Absent

 Ref.

 

 Ref.

 

 present

1.839 (1.422–2.379)

< 0.001

1.164 (0.872–1.554)

0.303

Sex

    

 Male

 Ref.

   

 Female

0.95 (0.773–1.167)

0.625

  

Family history of cancer

    

 No

 Ref.

   

 Yes

1.055 (0.752–1.482)

0.755

  

Post radiotherapy

    

 No

 Ref.

   

 Yes

0.965 (0.615–1.514)

0.877

  

Chemotherapy

    

 No

 Ref.

   

 Yes

0.936 (0.765–1.145)

0.518

  

Vascular invasion

    

 Absent

 Ref.

 

 Ref.

 

 Present

2.304 (1.844–2.88)

< 0.001

1.137 (0.874–1.478)

0.338

perineural invasion

    

 Absent

 Ref.

 

 Ref.

 

 Present

2.541 (2.054–3.143)

< 0.001

1.690 (1.328–2.151)

< 0.001

Histological grade

    

 Well

 Ref.

 

 Ref.

 

 Moderately

1.086 (0.8-1.474)

0.596

0.847 (0.620–1.156)

0.296

 Poorly

1.569 (1.09–2.258)

0.015

0.959 (0.659–1.397)

0.829

TNM stage

    

 I

 Ref.

 

 Ref.

 

 II

2.515 (1.474–4.291)

0.001

1.915 (1.103–3.323)

0.021

 III

5.032 (3.016–8.394)

< 0.001

2.370 (1.248–4.501)

0.008

 IV

15.665 (9.226–26.6)

< 0.001

7.955 (4.280-14.785)

< 0.001

Primary tumor location

    

 Right colon

 Ref.

   

 Left colon

1.207 (0.911-1.6)

0.189

  

 Rectum

0.891 (0.693–1.145)

0.366

  

ASA

    

 1

 Ref.

   

 2

1.029 (0.383–2.763)

0.955

  

 3

1.164 (0.426–3.182)

0.767

  

 4

1.812 (0.653–5.025)

0.254

  

Previous history of abdominal surgery

    

 No

 Ref.

   

 Yes

0.852 (0.649–1.119)

0.250

  

Neoadjuvant chemotherapy

    

 No

 Ref.

   

 Yes

1.321 (0.88–1.982)

0.179

  

Preoperative comorbidities

    

Any preoperative comorbidities

    

 No

 Ref.

 

 Ref.

 

 Yes

1.386 (1.12–1.716)

0.003

1.176 (0.742–1.863)

0.489

Cardiovascular disease

    

 No

 Ref.

 

 Ref.

 

 Yes

1.403 (1.122–1.755)

0.003

1.035 (0.638–1.679)

0.890

Cerebrovascular disease

    

 No

 Ref.

   

 Yes

1.334 (0.711-2.5)

0.369

  

COPD

    

 No

 Ref.

   

 Yes

1.357 (0.78–2.36)

0.279

  

Diabetes

    

 No

 Ref.

   

 Yes

0.963 (0.655–1.416)

0.849

  

Hematological diseases

    

 No

 Ref.

   

 Yes

2.082 (0.519–8.361)

0.301

  

CEA (ng/mL)

    

 Normal

 Ref.

 

 Ref.

 

 High

2.038 (1.665–2.495)

< 0.001

1.305 (1.046–1.629)

0.019

CA19-9 (kU/L)

    

 Normal

 Ref.

 

 Ref.

 

 High

2.006 (1.594–2.523)

< 0.001

1.257 (0.983–1.609)

0.068

CA72-4 (U/mL)

    

 Normal

 Ref.

   

 High

1.298 (0.987–1.708)

0.062

  

CA125 (U/mL)

    

 Normal

 Ref.

 

 Ref.

 

 High

2.156 (1.644–2.827)

< 0.001

1.430 (1.054–1.939)

0.021

  1. Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); ASA, American Society of Anesthesiologists Physical Status Classification; COPD, chronic obstructive pulmonary disease; CEA, carcino-embryonic antigen; CA19-9; CA72-4; CA125, carbohydrate antigen; LNs, Number of lymph nodes examined; PLNs, Number of positive lymph nodes
  2. Bold was used to highlight values that were statistically significant (< 0.05)